Skip to main content
. 2022 May 9;9(4):2407–2418. doi: 10.1002/ehf2.13934

Table 2.

Secondary outcomes: changes from baseline to 3 months

Control (n = 15) HBCR (n = 15) Difference between the control and HBCR groups in the changes from baseline to 3 months
Baseline 3 months Change Baseline 3 months Change (95%CI) P value
BNP (pg/mL) 192 ± 219 188 ± 229 −4.3 ± 44.0 237 ± 263 211 ± 239 −25.1 ± 81.4 −20.8 (−69.8 to 28.2) 0.39
KCCQ 74.1 ± 23.1 78.0 ± 23.0 3.9 ± 10.8 70.2 ± 25.6 70.3 ± 27.7 0.04 ± 7.2 −3.9 (−10.8 to 3.0) 0.26
SPPB 10.4 ± 2.2 10.5 ± 2.0 0.1 ± 0.2 11.1 ± 1.2 11.4 ± 1.1 0.2 ± 0.1 0.2 (−0.2 to 0.7) 0.41
Kihon checklist 6.5 ± 3.7 4.8 ± 3.1 −1.7 ± 2.2 6.1 ± 4.1 5.4 ± 2.9 −0.6 ± 2.6 1.1 (−0.7 to 2.9) 0.23

Data are expressed as mean ± standard deviation. P values are derived by unpaired t‐test.

95%CI, 95% confidence interval; BNP, brain natriuretic peptide; HBCR, home‐base cardiac rehabilitation; KCCQ, Kansas City Cardiomyopathy Questionnaire; SPPB, Short Physical Performance Battery.